Organization & Leadership

Affiliated with Novartis Biomedical Research and the University of Basel, the FMI is a not-for-profit foundation funded by Novartis and competitive research grants. The FMI has a streamlined organizational structure consisting of research groups, technology platforms, and a lean administrative team. The institute is led by the Director, who is supported by the group leaders and an administrative management team. Strategic guidance and scientific evaluation are provided by the Scientific Advisory Board (SAB), which is composed of internationally renowned researchers.

FMI DIRECTOR

Dirk Schübeler

Born in Germany, Dirk Schübeler obtained his PhD from the Technical University in Braunschweig, Germany, working with Jürgen Bode. He then worked as a postdoctoral fellow at the Hutchinson Cancer Center in Seattle, USA, with Mark Groudine. Dirk joined the FMI in 2003 as a junior group leader, in 2008 he was appointed senior group leader, and in 2011 he became adjunct professor at the University of Basel. Dirk’s research focuses on understanding gene regulation and the function of chromatin. He received several awards for his research including the Friedrich Miescher Price of the Swiss Society for Biochemistry (2007), the Novartis VIVA Leading Scientist Award (2011), the ESCI Award for Excellence in Basic/Translational Research (2014) and three prestigious ERC grants.
Dirk led the FMI as co-director ad interim from March 2019 until April 2020, together with Silvia Arber. In April 2020, he was appointed Director of the FMI. Since 2021, Dirk has been a Full Professor of Molecular Biology at the University of Basel.

» More about Dirk Schübeler’s research at the FMI

RESEARCH GROUP LEADERS

TECHNOLOGY PLATFORM HEADS

ADMINISTRATION & INFRASTRUCTURE HEADS

FMI FORMER DIRECTORS